The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

  title={The neurobiology of psychedelic drugs: implications for the treatment of mood disorders},
  author={F. Vollenweider and M. Kometer},
  journal={Nature Reviews Neuroscience},
  • F. Vollenweider, M. Kometer
  • Published 2010
  • Psychology, Medicine
  • Nature Reviews Neuroscience
  • After a pause of nearly 40 years in research into the effects of psychedelic drugs, recent advances in our understanding of the neurobiology of psychedelics, such as lysergic acid diethylamide (LSD), psilocybin and ketamine have led to renewed interest in the clinical potential of psychedelics in the treatment of various psychiatric disorders. Recent behavioural and neuroimaging data show that psychedelics modulate neural circuits that have been implicated in mood and affective disorders, and… CONTINUE READING
    348 Citations
    Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
    Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.
    • 10
    • Highly Influenced
    • PDF
    Animal models of serotonergic psychedelics.
    • 75
    Neurobiological Augmentation of Psychotherapy in Treatment Resistant Depression
    • 2
    • PDF
    Psychedelics and music: neuroscience and therapeutic implications
    • 10
    Psychedelics in the treatment of unipolar mood disorders: a systematic review
    • 37
    • PDF


    Serotonin research: contributions to understanding psychoses.
    • 293
    • PDF
    Neurocognitive mechanisms in depression: implications for treatment.
    • 305
    • PDF
    Antidepressant effects of ketamine in depressed patients
    • 2,269
    • PDF
    Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
    • C. Large
    • Psychology, Medicine
    • Journal of psychopharmacology
    • 2007
    • 88